Numerous scientific studies have now shown that GH drives progression of breast and endometrial [3,9,11,15,24,25,46,47,48,49,50,51,52,53,54], colorectal [18,19], thyroid [22], and hepatocellular carcinoma [23]. Here, GH1 is linked to hepatocellular carcinoma.